HBK Investments L P Acquires New Shares in Tempus AI, Inc. (NASDAQ:TEM)

HBK Investments L P acquired a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 150,000 shares of the company's stock, valued at approximately $5,064,000. HBK Investments L P owned approximately 0.10% of Tempus AI as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of TEM. Operose Advisors LLC bought a new stake in Tempus AI during the 4th quarter valued at $25,000. Farther Finance Advisors LLC bought a new stake in Tempus AI during the 4th quarter valued at $34,000. Prestige Wealth Management Group LLC increased its stake in Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock valued at $36,000 after purchasing an additional 965 shares in the last quarter. NewEdge Advisors LLC bought a new stake in Tempus AI during the 4th quarter valued at $49,000. Finally, First Horizon Advisors Inc. increased its stake in Tempus AI by 207.9% during the 4th quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company's stock valued at $55,000 after purchasing an additional 1,108 shares in the last quarter. Institutional investors own 24.22% of the company's stock.

Insider Transactions at Tempus AI

In related news, EVP Andrew Polovin sold 13,135 shares of Tempus AI stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $45.98, for a total value of $603,947.30. Following the completion of the transaction, the executive vice president now directly owns 154,171 shares in the company, valued at approximately $7,088,782.58. The trade was a 7.85 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director David R. Epstein sold 990 shares of Tempus AI stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $46.83, for a total transaction of $46,361.70. Following the completion of the transaction, the director now owns 26,284 shares of the company's stock, valued at $1,230,879.72. This represents a 3.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 4,584,252 shares of company stock worth $272,870,580 in the last quarter. Insiders own 27.60% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on TEM. BTIG Research began coverage on shares of Tempus AI in a research note on Monday, April 21st. They set a "buy" rating and a $60.00 price target for the company. JPMorgan Chase & Co. downgraded shares of Tempus AI from an "overweight" rating to a "neutral" rating and increased their target price for the company from $50.00 to $55.00 in a report on Tuesday, February 25th. Guggenheim restated a "buy" rating on shares of Tempus AI in a report on Tuesday, February 25th. Bank of America increased their price objective on shares of Tempus AI from $54.00 to $60.00 and gave the company a "neutral" rating in a research note on Monday, March 3rd. Finally, Morgan Stanley lifted their target price on shares of Tempus AI from $50.00 to $60.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Six analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, Tempus AI currently has an average rating of "Moderate Buy" and an average target price of $61.08.

Tempus AI Price Performance

Shares of TEM stock traded up $0.87 during trading hours on Monday, hitting $53.77. 10,846,035 shares of the company were exchanged, compared to its average volume of 5,673,698. The firm has a fifty day simple moving average of $49.28 and a 200 day simple moving average of $50.52. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $91.45.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.